Patent · US Active

Composition comprising at least two influenza A virus-neutralizing-binding molecules

US10703802B2 · kind B2 · utility

1Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2014
Grant dateJul 7, 2020
Priority date
Expiry dateSep 12, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a composition comprising at least two influenza A virus-neutralizing binding molecules that bind to an epitope in the stem region of influenza A virus hemagglutinin (HA) protein, the method comprising: i) a first binding molecule capable of neutralizing at least one influenza A virus subtype selected from the group consisting of H1, H2, H5 and H9; ii) a second binding molecule capable of neutralizing at least one influenza A virus subtype selected from the group consisting of H1, H3, H5, H7 and H9. The mixed composition of the present invention can effectively neutralize the multiple influenza subtypes of both phylogenetic group 1 and phylogenetic group 2 and can be used in combination with a chemical compound. Thus, the composition of the present invention is very useful for the prevention and treatment of a disease by influenza virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.